MRE269 是一种口服的长效前列环素受体激动剂前药，是 Selexipag 的活性代谢物，用于治疗肺动脉高压。

MRE-269 is an orally available and long-acting prostacyclin receptor agonist prodrug. MRE-269 is used for the treatment of pulmonary arterial hypertension. MRE-269 is an active metabolite of Selexipag (S253150).

475085-57-5

C25H29N3O3

419.525

MRE 269;3-氧代-12-烯-28-乌苏酸;MRE269;ACT-333679

DMSO:51 mg/mL
Powder: -20°C for 3 years
In solvent: -80°C for 2 years